|
TMEM167A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28360000406502E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12630000168335E-08 |
| Normal-vs-Stage2 |
2.691900E-02 |
| Normal-vs-Stage3 |
2.79490000032467E-08 |
| Normal-vs-Stage4 |
2.20810003614957E-09 |
| Stage1-vs-Stage2 |
3.638100E-02 |
| Stage1-vs-Stage3 |
2.184400E-01 |
| Stage1-vs-Stage4 |
1.486170E-02 |
| Stage2-vs-Stage3 |
1.219640E-02 |
| Stage2-vs-Stage4 |
1.739740E-03 |
| Stage3-vs-Stage4 |
1.982230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32589997156896E-09 |
| Normal-vs-AfricanAmerican |
4.00200000000295E-05 |
| Normal-vs-Asian |
3.99699995323743E-09 |
| Caucasian-vs-AfricanAmerican |
9.219000E-01 |
| Caucasian-vs-Asian |
2.744400E-01 |
| AfricanAmerican-vs-Asian |
5.541000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87449999861289E-08 |
| Normal-vs-Female |
5.14360000147818E-08 |
| Male-vs-Female |
3.102600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.78049999480734E-08 |
| Normal-vs-Age(41-60Yrs) |
1.82799997361371E-09 |
| Normal-vs-Age(61-80Yrs) |
6.52300000014705E-07 |
| Normal-vs-Age(81-100Yrs) |
1.816160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.041000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.714200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.520200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.082600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.990190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.051400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.251900E-02 |
| Classical-VS-Follicular |
1.098000E-02 |
| Classical-VS-Other |
3.016200E-01 |
| Classical-VS-Normal |
6.03859995340628E-09 |
| Tall-VS-Follicular |
2.554900E-04 |
| Tall-VS-Other |
9.197200E-01 |
| Tall-VS-Normal |
5.18700005169848E-09 |
| Follicular-VS-Other |
1.048420E-01 |
| Follicular-VS-Normal |
7.115800E-03 |
| Other-VS-Normal |
6.982400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11570000016492E-07 |
| Normal-vs-N1 |
1.30709999490719E-08 |
| N0-vs-N1 |
2.940000E-02 |
|
|
